Stuart Grant Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stuart Grant.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stuart Grant. Stuart Grant is SR VP & CFO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and EVP and CFO in Patheon N.V. ($PTHN).
Stuart Grant in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stuart Grant: SR VP & CFO
Holdings: 57,102 shares
Current Value: $323,768
Latest Transaction: Mar 18 2011
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stuart Grant in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 17,000 | 20,400 | 38,751 | |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 31,385 | 37,662 | 55,751 | |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 16,615 | 19,938 | 87,136 | |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 3.40 | 6,000 | 20,400 | 57,102 | 63.1 K to 57.1 K (-9.51 %) |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 17,000 | 20,400 | 63,102 | 46.1 K to 63.1 K (+36.87 %) |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 31,385 | 37,662 | 46,102 | 14.7 K to 46.1 K (+213.26 %) |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 3.39 | 16,615 | 56,325 | 14,717 | 31.3 K to 14.7 K (-53.03 %) |
| Mar 18 2011 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 16,615 | 19,938 | 31,332 | 14.7 K to 31.3 K (+112.90 %) |
| Aug 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 2,500 | 3,000 | 103,751 | |
| Aug 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 6.20 | 2,500 | 15,500 | 11,717 | 14.2 K to 11.7 K (-17.58 %) |
| Aug 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 2,500 | 3,000 | 14,217 | 11.7 K to 14.2 K (+21.34 %) |
| Jun 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 1,250 | 1,500 | 106,251 | |
| Jun 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 6.97 | 1,250 | 8,713 | 11,717 | 13 K to 11.7 K (-9.64 %) |
| Jun 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 1,250 | 1,500 | 12,967 | 11.7 K to 13 K (+10.67 %) |
| May 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 1,250 | 1,500 | 107,501 | |
| May 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 7.68 | 1,250 | 9,600 | 11,717 | 13 K to 11.7 K (-9.64 %) |
| May 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 1,250 | 1,500 | 12,967 | 11.7 K to 13 K (+10.67 %) |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 3.26 | 36,990 | 120,587 | 35,938 | |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 3.26 | 1,563 | 5,095 | 72,928 | |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 8.31 | 36,990 | 307,387 | 9,000 | 46 K to 9 K (-80.43 %) |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 3.26 | 36,990 | 120,587 | 45,990 | 9 K to 46 K (+411.00 %) |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 8.26 | 1,563 | 12,910 | 9,000 | 10.6 K to 9 K (-14.80 %) |
| Apr 30 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 3.26 | 1,563 | 5,095 | 10,563 | 9 K to 10.6 K (+17.37 %) |
| Apr 14 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 3.26 | 509 | 1,659 | 74,491 | |
| Apr 14 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 8.26 | 509 | 4,204 | 11,717 | 12.2 K to 11.7 K (-4.16 %) |
| Apr 14 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 3.26 | 509 | 1,659 | 12,226 | 11.7 K to 12.2 K (+4.34 %) |
| Apr 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 1,249 | 1,499 | 108,751 | |
| Apr 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 6.97 | 13 | 91 | 11,717 | 11.7 K to 11.7 K (-0.11 %) |
| Apr 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 6.96 | 1,236 | 8,603 | 11,730 | 13 K to 11.7 K (-9.53 %) |
| Apr 06 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 1,249 | 1,499 | 12,966 | 11.7 K to 13 K (+10.66 %) |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | M | 1.20 | 15,000 | 18,000 | 110,000 | |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 6.68 | 45,000 | 300,600 | 45,000 | |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 6.96 | 15,000 | 104,370 | 9,000 | 24 K to 9 K (-62.50 %) |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | M | 1.20 | 15,000 | 18,000 | 24,000 | 9 K to 24 K (+166.67 %) |
| Jan 25 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Sell | S | 7.02 | 17,027 | 119,530 | 9,000 | 26 K to 9 K (-65.42 %) |
| Jan 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Payment of Exercise | F | 6.46 | 7,812 | 50,466 | 26,027 | 33.8 K to 26 K (-23.09 %) |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 1.20 | 125,000 | 150,000 | 125,000 | |
| Feb 03 2009 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | P | 1.62 | 3,000 | 4,845 | 6,000 | 3 K to 6 K (+100.00 %) |
| Aug 04 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Buy | P | 2.82 | 3,000 | 8,466 | 3,000 | 0 to 3 K |
| May 23 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 0.00 | 24,839 | 0 | 24,839 | |
| Mar 18 2008 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 3.26 | 75,000 | 244,500 | 75,000 | |
| Aug 29 2007 | BCRX | BIOCRYST PHARMACEU ... | Grant Stuart | SR VP & CFO | Option Exercise | A | 11.39 | 200,000 | 2,278,000 | 200,000 |
Page: 1